BIOMOLECULAR CHARACTERISTIC IDENTIFICATION METHOD AND SYSTEM THEREOF FOR TAIWAN TILAPIA STRAINS
20230349001 · 2023-11-02
Inventors
Cpc classification
C12Q1/6888
CHEMISTRY; METALLURGY
International classification
Abstract
A biomolecular characteristic identification method includes: breeding a plurality of Taiwan Tilapias in a predetermined environment to obtain a plurality of baited Taiwan Tilapias; seeking at least one nucleotide mark in the baited Taiwan Tilapias to obtain at least one feature sequence marker therefrom; producing at least one design of primer pair according to the feature sequence marker for identification; and identifying an unknown DNA sample of the baited Taiwan Tilapias with the at least one primer pair in a biomolecular tracing procedure to obtain an identification result.
Claims
1. A biomolecular characteristic identification system for Taiwan Tilapia strains comprising: a predetermined environment conditioned and provided to breed and train a plurality of Taiwan Tilapias to obtain a plurality of baited Taiwan Tilapias; at least one feature sequence marker obtained from seeking at least one nucleotide mark in the baited Taiwan Tilapias; at least one designed primer pair corresponding to the feature sequence marker for identification and produced according to the feature sequence marker; and an identification result obtained from identifying an unknown DNA sample of the baited Taiwan Tilapias with the at least one primer pair in a biomolecular tracing procedure; wherein the identification result shows a correct source of original baited Taiwan Tilapias or an incorrect source of original baited Taiwan Tilapias.
2. The biomolecular characteristic identification system as defined in claim 1, wherein the feature sequence marker is selected from a cold hardiness marker, a disease resistance marker, a salinity tolerance marker or combinations thereof.
3. The biomolecular characteristic identification system as defined in claim 2, wherein the cold hardiness marker is selected from a (ATT).sub.n-sequence-contained marker, a (G).sub.n-sequence-contained marker, a (GAG).sub.n-sequence-contained marker, a (GT).sub.n-sequence-contained marker or a (CA).sub.n-sequence-contained marker.
4. The biomolecular characteristic identification system as defined in claim 2, wherein the salinity tolerance marker is selected from a (CA).sub.11-sequence-contained marker, a (AT).sub.8-sequence-contained marker, a (TAT).sub.8-sequence-contained marker, a (TTTG).sub.5-sequence-contained marker or a (AT).sub.12-sequence-contained marker.
5. The biomolecular characteristic identification system as defined in claim 2, wherein the disease resistance marker is selected from a (CAGG).sub.7-sequence-contained marker, a (CTAC).sub.7-sequence-contained marker, a (TTGA).sub.20-sequence-contained marker, a (TTGT).sub.10-sequence-contained marker or a (GAAAA).sub.6-sequence-contained marker.
6. A biomolecular characteristic identification method for Taiwan Tilapia strains comprising: breeding and training a plurality of Taiwan Tilapias in a predetermined environment to obtain a plurality of baited Taiwan Tilapias; seeking at least one nucleotide mark in the baited Taiwan Tilapias to obtain at least one feature sequence marker therefrom; producing at least one design of primer pair according to the feature sequence marker for identification; and identifying an unknown DNA sample of the baited Taiwan Tilapias with the at least one primer pair in a biomolecular tracing procedure to obtain an identification result.
7. The biomolecular characteristic identification method as defined in claim 6, wherein the feature sequence marker is selected from a cold hardiness marker, a disease resistance marker, a salinity tolerance marker or combinations thereof.
8. The biomolecular characteristic identification method as defined in claim 7, wherein the cold hardiness marker is selected from a (ATT).sub.n-sequence-contained marker, a (G).sub.n-sequence-contained marker, a (GAG).sub.n-sequence-contained marker, a (GT).sub.n-sequence-contained marker or a (CA).sub.n-sequence-contained marker.
9. The biomolecular characteristic identification method as defined in claim 7, wherein the salinity tolerance marker is selected from a (CA).sub.n-sequence-contained marker, a (AT).sub.8-sequence-contained marker, a (TAT).sub.8-sequence-contained marker, a (TTTG).sub.5-sequence-contained marker or a (AT).sub.12-sequence-contained marker.
10. The biomolecular characteristic identification method as defined in claim 7, wherein the disease resistance marker is selected from a (CAGG).sub.7-sequence-contained marker, a (CTAC).sub.7-sequence-contained marker, a (TTGA).sub.20-sequence-contained marker, a (TTGT).sub.10-sequence-contained marker or a (GAAAA).sub.6-sequence-contained marker.
11. The biomolecular characteristic identification method as defined in claim 6, further comprising an exogenous biomolecular tracing method comprising: extracting a first nucleotide marker from a first marker source organism; combining a first basic material with the first nucleotide marker to form a first nucleotide marker-contained material; extracting a second nucleotide marker from a second marker source organism; combining a second basic material with the second nucleotide marker to form a second nucleotide marker-contained material; in a first stage, exogenously combining the first nucleotide marker-contained material with an aquatic creature or an aquatic product to form a first exogenously-marked aquatic creature or a first exogenously-marked aquatic product; in a second stage, exogenously combining the second nucleotide marker-contained material with the first exogenously-marked aquatic creature or the first exogenously-marked aquatic product to form a second exogenously-marked aquatic creature or a second exogenously-marked aquatic product; and identifying a DNA sample received from the second exogenously-marked aquatic creature or the second exogenously-marked aquatic product with at least one primer pair in an exogenous biomolecular tracing procedure to obtain an exogenously-marked identification result.
12. The method as defined in claim 11, wherein the first or second nucleotide marker is selected from a DNA extract, a DNA extract liquid, a DNA extract powder, a DNA extract-related material or combinations thereof.
13. The method as defined in claim 11, wherein exogenously combining the first or second nucleotide marker-contained material with the aquatic creature or the aquatic product includes a feeding process, a dipping process, a painting process, a spraying process or combinations thereof.
14. The method as defined in claim 11, wherein the at least one primer pair is applied to execute a test of polymerase chain reaction (PCR) or loop-mediated isothermal amplification (LAMP).
15. The method as defined in claim 11, wherein the exogenously-marked identification result includes a combination set of codes or code forms for tracing the second exogenously-marked aquatic creature or the second exogenously-marked aquatic product.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0045] The present invention will become more fully understood from the detailed description given hereinbelow and the accompanying drawings which are given by way of illustration only, and thus are not limitative of the present invention, and wherein:
[0046]
[0047]
[0048]
[0049]
[0050]
DETAILED DESCRIPTION OF THE INVENTION
[0051] It is noted that a biomolecular characteristic identification method (or usage) and system (e.g., information system) thereof for Taiwan Tilapia strains in accordance with the preferred embodiment of the present invention can be applicable to various aquatic creature baiting systems, various aquatic fry or creature breeding systems, various aquatic creature display systems, various algae (or microalgae) cultivation systems or various algae display systems, which are not limitative of the present invention.
[0052] For instance, a biomolecular characteristic identification method (or usage) and system (e.g., information system) thereof for Taiwan Tilapia strains in accordance with the preferred embodiment of the present invention can be suitable for a Taiwan Tilapia strain (National Taiwan Ocean University), including Taiwan Tilapia (A), Taiwan Tilapia (Y), Taiwan Tilapia (B), Taiwan Tilapia (T) or other related Taiwan Tilapia strains, which are not limitative of the present invention.
[0053]
[0054] With continued reference to
[0055] Still referring to
[0056] With continued reference to
[0057]
[0058]
[0059] Still referring to
[0060] Still referring to
[0061] Still referring to
[0062] With continued reference to
[0063] Still referring to
[0064] By way of example, the cold hardiness marker can be selected from a (ATT).sub.n-sequence-contained marker as follows:
TABLE-US-00001 Seq. 1:GACTACATCCCAGCAACAGTGACACATTCCACCGCGAGCCCAC CCTCCACCTTCCCAACACTACCATTATTATTATTATTATTATTATTATTA TTATTATTATTATTATTTGTATTTTTTTACTTGGAGCAACCCGCCACGCT CCCCTTGCACATGGACTGGAAAGATGATAGCCT
TABLE-US-00002 Seq. 2:GACTACATCCCAGCAACAGTGACACATTCCACCGCGAGCCCAC CCTCCACCTTCCCAACACTACTATTATTATTATTATTATTATTATTATTA TTATTATTATTATTATTATTATTATTATTTTTATTTTTTTACTTGGAGCA ACCCGCCACGCTCCCCTTGCACATGGACTGGAAAGATGATAGCCT
[0065] By way of example, the (ATT).sub.n-sequence-contained marker can be identified by forward primer Seq. 3 and reverse primer Seq. 4 of primer pair 3a as follow:
TABLE-US-00003 Seq. 3: GACTACATCCCAGCAACAGTGA
TABLE-US-00004 Seq. 4: AGGCTATCATCTTTCCAGTCCA
[0066] By way of example, the cold hardiness marker can be selected from a (G).sub.n-sequence-contained marker as follows:
TABLE-US-00005 Seq. 5:ATGAGGTGAACAAAAGCCAATGGTTTCCAGACTCCACCCAAAC ACAACCTTTTAGTGTTTTTTAAAATAAAGCCTAAATGGGGGGGGGGGGGG TCGTGTTCAGCCCCCACTTGCTTACGCTTTACTAAGCGGCGAGTTAAGTC TCTGTCAAGGA
TABLE-US-00006 Seq. 6:ATGAGGTGAACAAAAGCCAATGGTTTCCAGACTCCACCCAAAC ACAACCTTTTAGTGTTTTTTAAAATAAAGCCTAAATGGGGGGGGGGGTCG TGTTCAGCCCCCACTTGCTTACGCTTTACTAAGCGGCGAGTTAAGTCTCT GTCAAGGA
[0067] By way of example, the (G).sub.n-sequence-contained marker can be identified by forward primer Seq. 7 and reverse primer Seq. 8 of primer pair 3a as follow:
TABLE-US-00007 Seq. 7: ATGAGGTGAACAAAAGCCAATGG
TABLE-US-00008 Seq. 8: TCCTTGACAGAGACTTAACTCGC
[0068] By way of example, the cold hardiness marker can be selected from a (GAG).sub.n-sequence-contained marker as follows:
TABLE-US-00009 Seq. 9:TATGGGCTGGAGAGGAGACTAAAGGAGGTGTGAGAGGAGGCGC CTCCTTATAGGACAGTGCTCTCGCTCTCCAGGTCACAGTCTTTAGGAAGA GGCGGCGAGGAGGAGGAGGAGGAGGAGAAGGCGGTGGCAGTCGGCAGCTG CTGGTCTACTGCCGTGAAGTC
TABLE-US-00010 Seq. 10:TATGGGCTGGAGAGGAGACTAAAGGAGGTGTGAGAGGAGGCG CCTCCTTATAGGACAGTGCTCTCGCTCTCCAGGTCACAGTCTTTAGGAAG AGGCGGCGAGGAGGAGAAGGCGGTGGCAGTCGGCAGCTGCTGGTCTACTG CCGTGAAGTC
[0069] By way of example, the (GAG).sub.n-sequence-contained marker can be identified by forward primer Seq. 11 and reverse primer Seq. 12 of primer pair 3a as follow:
TABLE-US-00011 Seq. 11: TATGGGCTGGAGAGGAGACTAA
TABLE-US-00012 Seq. 12: GACTTCACGGCAGTAGACCAG
[0070] By way of example, the cold hardiness marker can be selected from a (GT).sub.n-sequence-contained marker as follows:
TABLE-US-00013 Seq. 13:GAGCGTTGTTGTGTTTCTGCTATTAAGTGTGTGTGTGTGTGT AGCACCAGCATGATGTCGGACTTTGACATCATGCTCGCCCGGAGGAAAGC CATGAACAGCAAGAAGAG
TABLE-US-00014 Seq. 14:GAGCGTTGTTGTGTTTCTGCTATTAAAAAAGTGTGTGTGTGT GTGTGTGTGTGTGTGTGTGTGTGTGTGTAGCACTAGCGTGATGTCGGACT TCGACATCATGCTCGCCCGGAGGAAAGCCATGAACAGCAAGAAGAG
[0071] By way of example, the (GT).sub.n-sequence-contained marker can be identified by forward primer Seq. 15 and reverse primer Seq. 16 of primer pair 3a as follow:
TABLE-US-00015 Seq. 15: GAGCGTTGTTGTGTTTCTGCTA
TABLE-US-00016 Seq. 16: CTCTTCTTGCTGTTCATGGCTT
[0072] By way of example, the cold hardiness marker can be selected from a (CA).sub.n-sequence-contained marker as follows:
TABLE-US-00017 Seq. 17:ACAGCAGGAGGAGAGGAGAGAGGGGAGGAGCAGACTGAACTT CATAGACACCGGTCCCCTCGGCTCACCCCTCTCATTCACACACACACACA CACACACACACACAGTCGCACCTAATGTGAATACTTTGGGTTTGTGGCAG CAGTGTGGATGTTTCTTTGTGTCGCTGAACT
TABLE-US-00018 Seq. 18:ACAGCAGGAGGAGAGGAGAGAGGGGAGGAGCAGACTGA ACTTCATAGACACCGGTCCCCTCGGCTCACCCCTCTCATTCACACACACA CACACACACACACACACACACACACACACACACAGTCGCACCTAATGTGA ATACTTTGGGTTTGTGGCAGCAGTGTGGATGTTTCTTTGTGTCGCTGAAC T
[0073] By way of example, the (CA).sub.n-sequence-contained marker can be identified by forward primer Seq. 19 and reverse primer Seq. 20 of primer pair 3a as follow:
TABLE-US-00019 Seq. 19: ACAGCAGGAGGAGAGGAGAGA
TABLE-US-00020 Seq. 20: AGTTCAGCGACACAAAGAAACA
[0074] By way of example, the salinity tolerance marker can be selected from a (CA).sub.11-sequence-contained marker as follows:
TABLE-US-00021 Seq. 21:ACTCCCATACTGTATTTGCGTGTCTGTTTGTGTGTGCAGAGC AGGTTCTCTGGTCATACACACGCACACACACACACACACACACACGCCCT GTCGATTTCTTATTTCTGCTGATAAAGAAGAGGAGGCACTTGTGAAATGA AC
[0075] By way of example, the (CA).sub.11-sequence-contained marker can be identified by forward primer Seq. 22 and reverse primer Seq. 23 of primer pair 3a as follow:
TABLE-US-00022 Seq. 22: ACTCCCATACTGTATTTGCGTGT
TABLE-US-00023 Seq. 23: GTTCATTTCACAAGTGCCTCCTC
[0076] By way of example, the salinity tolerance marker can be selected from a (AT).sub.8-sequence-contained marker as follows:
TABLE-US-00024 Seq. 24:AGCAGATTAACATTGAAATAGGCTGTAAAAAAAAAATA GAGAAAAGCACAGAAAATAATAGACAAAGGTCTGTCTGAATATATATATA TATATATACATACACTATCTTAAAAATTAAAAAAAAAAACATTAAACATA AGGTAGTGTAAAAACAAGTTGTATAGACAATGAAATACAAAATCATCTCA TAAAAGAATTAATGTAATTCTGTGTTTCTGAATTTGCTTTTCTACTCACA CAG
[0077] By way of example, the (AT).sub.8-sequence-contained marker can be identified by forward primer Seq. 25 and reverse primer Seq. 26 of primer pair 3a as follow:
TABLE-US-00025 Seq. 25: AGCAGATTAACATTGAAATAGGCT
TABLE-US-00026 Seq. 26: CTGTGTGAGTAGAAAAGCA
[0078] By way of example, the salinity tolerance marker can be selected from a (TAT).sub.8-sequence-contained marker as follows:
TABLE-US-00027 Seq. 27:TAAAGCAACTTTTGTGGGCAAGTTTGATCTGCTGGGTA TATTATTATTATTATTATTATTATTGTTATTGTTGGTTATTATACACATG GTGGCTCTGCTTGTAAAGTGAAA
[0079] By way of example, the (TAT).sub.8-sequence-contained marker can be identified by forward primer Seq. 28 and reverse primer Seq. 29 of primer pair 3a as follow:
TABLE-US-00028 Seq. 28: TAAAGCAACTTTTGTGGGCAAGT
TABLE-US-00029 Seq. 29: TTTCACTTTACAAGCAGAGCCAC
[0080] By way of example, the salinity tolerance marker can be selected from a (TTTG).sub.5-sequence-contained marker as follows:
TABLE-US-00030 Seq. 30:AGGGTTTAAAGAGAGTTTGGCCTAGTCAACATATTTTT GTTTGTTTGTTTGTTTGTATGTATGTGTGTTTGTTTTGAATTGTGTTGAG CTGAACTAGATTTTGCATCTCTATAAAGAATTCAGGAATCCACTGTCTAA GGGCTA
[0081] By way of example, the (TTTG).sub.5-sequence-contained marker can be identified by forward primer Seq. 31 and reverse primer Seq. 32 of primer pair 3a as follow:
TABLE-US-00031 Seq. 31: AGGGTTTAAAGAGAGTTTGGCCT
TABLE-US-00032 Seq. 32: TAGCCCTTAGACAGTGGATTCCT
[0082] By way of example, the salinity tolerance marker can be selected from a (AT).sub.12-sequence-contained marker as follows:
TABLE-US-00033 Seq. 33:CAGTGTGAGTTTAACTTCGGGTCCAAGCCTTTCCGTCA CCCATATATATATATATATATATATATGTATATATAATTTTTTTGTTATT TTTTTGTGTATTTTTTATTTTTTTCCTCCCCAGTCTGGGATACCCACTAA AATG
[0083] By way of example, the (AT).sub.12-sequence-contained marker can be identified by forward primer Seq. 34 and reverse primer Seq. 35 of primer pair 3a as follow:
TABLE-US-00034 Seq. 34: CAGTGTGAGTTTAACTTCG
TABLE-US-00035 Seq. 35: CATTTTAGTGGGTATCC
[0084] By way of example, the disease resistance marker can be selected from a (CAGG).sub.7-sequence-contained marker as follows:
TABLE-US-00036 Seq. 36:GCACAGACACAGTAACACATGCACTGAGTATTCATTTG ACTGAGAGTATGTGCTAAATTTGATTTGGTTTTGTTTTCAGGCTTGTCAG CTGCCATTTAAACATGCATAGACAGCCAGGCAGGCAGGCAGGCAGGCAGG CAGGCGTCTGTGTGTCCCTGTTTCTGTTTGAAGTGGATGATCTCTGATCC CACGTACCTCTCTGATTGGGACATGCGTAGTCTCTCTCCGTCTGTCTGTT TTCCTTCTTCACCCCACGAAAGCTTTCTGAATCGAGTCAGGCAAAGCTGA AATAATACTGTTTGGAAAGGAAAATTAAATGACATAAAGAACTGTTTCTT TAATAAATGAAATAGGAAGCATGTACCAGGGAGT
[0085] By way of example, the (CAGG).sub.7-sequence-contained marker can be identified by forward primer Seq. 37 and reverse primer Seq. 38 of primer pair 3a as follow:
TABLE-US-00037 Seq. 37: GCACAGACACAGTAACACATGCAC
TABLE-US-00038 Seq. 38: ACTCCCTGGTACATGCTTCCTA
[0086] By way of example, the disease resistance marker can be selected from a (CTAC).sub.7-sequence-contained marker as follows:
TABLE-US-00039 Seq. 39:CACCACTGTCAACTGGCTAATGGACCTAAGGGCAGACT ATCTATCTACCTATCTACCTACCTACCTACCTACCTACCTACGTACCTAC CTACAAACAATACACATGCACCCCAACTAATATTTGTTTAAGTGTCCCTT GGGAATCTGCACCCCAACCACATGCTTTGGTAGCCTGTCTAAACTGTTTT AACTTGCAACATATATCAGGGTTTGATACCTGCCAACAGTAGTGAAATCT CATATTGAATTAAATGACCAAAATCTTCTTCAAAGTAGCTTTATACTCGA ATCGATTTTCTAGAATTAAATTCAAACATATTTTACAGTTGTGATAGTGC CTGCGGTATCAAGAAGGTAAC
[0087] By way of example, the (CTAC).sub.7-sequence-contained marker can be identified by forward primer Seq. 40 and reverse primer Seq. 41 of primer pair 3a as follow:
TABLE-US-00040 Seq. 40: CACCACTGTCAACTGGCTAATG
TABLE-US-00041 Seq. 41: GTTACCTTCTTGATACCGCAGG
[0088] By way of example, the disease resistance marker can be selected from a (TTGA).sub.20-sequence-contained marker as follows:
TABLE-US-00042 Seq. 42:GGACCCTGAATCTTCCCTTAGTTATGCTGCAAAAAGTG TAGAATGCTGGGAGATTCCCATGATGCATTGTGTATTTCTTCTTCAGTCG TCTTTTTGATTGATTGATTGATTGATTGATTGATTGATTGATTGATTGAT TGATTGATTGATTGATTGATTGATTGATTGATTGACTGGAGGAGAGCAGT TTGAGAACAGGAAAAAACAGCCATCTGGTCCTGCAGCCATACTCCGTCGC TGGAATCAGACCCACCTGGCTGCATCGAGTGGAAGTAGTCATTTATATTG TATATTGTATATTTCTGTCTGAGTACATGTGCATGTGTGCGTAAGTGTCT GTATCTTGTGTCCAACTCAAGAGAGAGAGCC
[0089] By way of example, the (TTGA).sub.20-sequence-contained marker can be identified by forward primer Seq. 43 and reverse primer Seq. 44 of primer pair 3a as follow:
TABLE-US-00043 Seq. 43: GGACCCTGAATCTTCCCTTAGT
TABLE-US-00044 Seq. 44: GGCTCTCTCTCTTGAGTTGGACA
[0090] By way of example, the disease resistance marker can be selected from a (TTGT).sub.10-sequence-contained marker as follows:
TABLE-US-00045 Seq. 45:ACTAGCAGATGATAAATGCGCCAGAAAATAAACGCTTA AAGGGAATATGCACCAGTCCAGCTGTTTGTTTGTTTGTTTGTTTGTTTGT TTGTTTGTTTGTTTTACTGCTCAAATTTTGTATTTGCACTGTTTCGGCTC AGTGTGACAGTTTTTTTGGTGTCAGCTCAGATTGCGAGGACATCTCTTGT GCGCAGACCTCTTCAGGGCACCCCACAGATTTTCTGTAGGATTTAGGTCT GGGCAT
[0091] By way of example, the (TTGT).sub.10-sequence-contained marker can be identified by forward primer Seq. 46 and reverse primer Seq. 47 of primer pair 3a as follow:
TABLE-US-00046 Seq. 46: ACTAGCAGATGATAAATGCGC
TABLE-US-00047 Seq. 47: ATGCCCAGACCTAAATCCTACA
[0092] By way of example, the disease resistance marker can be selected from a (GAAAA).sub.6-sequence-contained marker as follows:
TABLE-US-00048 Seq. 48:TGTATGTAGCCGAAGTAGCCAATCTCAACAGTACTTGC TTGTTTTAATTTATTTACTGGTTTGGTGCACTTTGTATTTAAGAAAAAAA ATTGATAACTGTAAACCACCATGGCAGACCCGATGGCATTTTCATGCTTC GCAACATCATTAGCGAATGATGTCTGTTCTGAAAAGAAAAGAAAAGAAAA GAAAAGAAAAGACCTTGACGTCCGTGGAAGTCAACAGCGGTGGATGACTG CAGAATCATTCGTGCGATCATCCACCACTGTTGAGAAACCCCTTCACAAC AGCCAACAAAATGAACAACACTCTGCAGGAGGAAGGCGTATCCAAGTATA CCATAAAGAGAAGACTGCAGGTAAGTAAATACAAAGGGTTCACTGCAAGG
[0093] By way of example, the (GAAAA).sub.6-sequence-contained marker can be identified by forward primer Seq. 49 and reverse primer Seq. 50 of primer pair 3a as follow:
TABLE-US-00049 Seq. 49: TGTATGTAGCCGAAGTAGCCAA
TABLE-US-00050 Seq. 50: CCTTGCAGTGAACCCTTTGTAT
[0094] Referring back to
[0095]
[0096]
[0097] With continued reference to
[0098] Still referring to
[0099] Still referring to
[0100] Still referring to
[0101] Still referring to
[0102] Although the invention has been described in detail with reference to its presently preferred embodiment, it will be understood by one of ordinary skills in the art that various modifications can be made without departing from the spirit and the scope of the invention, as set forth in the appended claims.